(Current allergy and asthma reports[TA])
1,805 results
  • Demystifying Genetic Workup of Inborn Errors of Immunity. [Review]
    Curr Allergy Asthma Rep. 2026 Oct 31; 26(1).L BM, V G, X P PCA
  • Genetically driven immune diseases (GIDs) are germline or somatic errors of immunity, representing an expanding and diagnostically complex group of genetic disorders. While genomic advances have enhanced their detection, interpretation of genetic data remains a major challenge due to significant genotypic and phenotypic heterogeneity, incomplete knowledge about genotype-phenotype connections, and…
  • A Review: Mast Cells as Targets for Glucocorticoid Action. [Review]
    Curr Allergy Asthma Rep. 2026 Oct 19; 26(1).Atum D, Ogwal JO, Obeny ACA
  • This review aims to summarize the established and potential targets of glucocorticoids (GCs) on mast cells, which are implicated in the pathophysiology of various allergic and inflammatory diseases including asthma, allergic rhinitis, and atopic dermatitis. We sought to answer the following questions: (1) How do glucocorticoids inhibit the release of mediators from mast cells? (2) What are the ef…
  • Obesity-Related Asthma: Structure and Inflammation. [Review]
    Curr Allergy Asthma Rep. 2026 Oct 14; 26(1).Tzeng TH, Kamau P, … Kloepfer KMCA
  • Asthma and obesity are affecting children and teenagers at higher rates than previous generations. Epidemiological data link obesity during childhood with the subsequent development of asthma. In this review we describe developmental and inflammatory factors that contribute to asthma severity in children with obesity.
  • Delayed Drug Hypersensitivity: Mechanistic Advances and Emerging Therapies. [Review]
    Curr Allergy Asthma Rep. 2026 Oct 13; 26(1).Siddiqui A, Chow TG, … Alvarez-Arango SCA
  • Delayed drug hypersensitivity reactions span mild cutaneous eruptions, severe cutaneous adverse reactions (SCARs), and internal-organ injury. We review how pharmacogenomic, single-cell, and spatial methods have shown that these syndromes are driven by shared effector mechanisms, and how identifying which one predominates opens the way to targeted treatment.
  • Under the Drapes: Unmasking the Mechanisms and Clinical Diagnosis of Perioperative Hypersensitivity. [Review]
    Curr Allergy Asthma Rep. 2026 Oct 01; 26(1).Ebo DG, Peeters L, … Vlaeminck NCA
  • Perioperative hypersensitivity reactions are uncommon but potentially life-threatening complications of anaesthesia and remain a major concern in clinical practice. This review provides an updated overview of the mechanisms and aetiologies underlying perioperative hypersensitivity and examines contemporary diagnostic strategies for identifying the responsible agent. Emphasis is placed on the inte…
  • Hypersensitivity Reactions to Biologics: Advances in Diagnosis and Management. [Review]
    Curr Allergy Asthma Rep. 2026 Sep 28; 26(1).Yang BCCA
  • The landscape of biologic therapeutics has expanded to include therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. As the use of these therapies expands, hypersensitivity reactions (HSRs) can limit the use of preferred treatments. This review examines advances in the diagnosis and management of these adverse events, including applications of precision medicine and Al…
  • Impact of Chronic Stress and Trauma on Asthma Pathophysiology and Outcomes. [Review]
    Curr Allergy Asthma Rep. 2026 Sep 21; 26(1).Friedman R, DePrince A, … Wang ECA
  • Chronic stress and trauma are potent risk factors for worsened asthma outcomes. We summarize recent research discoveries surrounding chronic stress, adverse childhood experiences (ACEs), and intimate partner abuse (IPA) and their impacts on asthma pathophysiology and outcomes. We also highlight treatment and precision medicine implications.
  • Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies. [Review]
    Curr Allergy Asthma Rep. 2026 Sep 16; 26(1).Mendez P, Rosado A, Cardet JCCA
  • Type 2-low (T2-low) asthma, characterized by low blood and sputum eosinophils and low fractional exhaled nitric oxide (FeNO), remains a major unmet need because of frequent corticosteroid insensitivity and a lack of targeted therapies. This review summarizes recent advances in its epidemiology, multiomics, and therapeutic landscape.
  • Military Standards for Anaphylaxis: Aligning Allergy Science, Operational Risk, and Waiver Documentation. [Review]
    Curr Allergy Asthma Rep. 2026 Sep 07; 26(1).Brimmer KE, Spriet S, Petersen MMCA
  • Allergic disease is common in the United States, and a growing number of otherwise qualified applicants and service members present with histories of food allergy, venom allergy, medication reactions, physical urticarias, or prior anaphylaxis. The challenge for clinicians is to translate a nuanced allergy-immunology evaluation into strict military accession and retention standards designed for re…
  • Targeting Tight Junction Proteins to Restore Airway Epithelial Barrier Function in Asthma. [Review]
    Curr Allergy Asthma Rep. 2026 Sep 04; 26(1).Ke S, Duan G, … Ouyang SCA
  • Asthma is increasingly recognized not only as an inflammatory disorder but also as a disease rooted in airway epithelial barrier dysfunction. This review examines tight junction proteins (TJPs) including occludin, claudins, and ZO family members, as central regulators of epithelial integrity and potential therapeutic targets.